Latest News about NYSE:MRK
Recent news which mentions NYSE:MRK
5 Defensive Stocks to Own for Consistent Dividends and Stable Earnings
February 24, 2022
From StockNews.com
3 Wide-Moat Stocks to Withstand a Market Downturn: Microsoft, Merck, and Blackbaud
February 24, 2022
From StockNews.com
Why This New Dad Says Every Company Should Offer Parental Leave
February 23, 2022
Tickers
MRK
Stabilize Your Portfolio with These 5 High-Quality Stocks
February 18, 2022
From StockNews.com
Is Canopy Growth a Smart Cannabis Stock to Own in 2022?
February 17, 2022
From StockNews.com
Paying Tribute to Our Black Leaders in Science
February 09, 2022
Tickers
MRK
This Leader Works To Ensure Diversity and Inclusion Is Visible in Everything We Do
February 04, 2022
Tickers
MRK
Giving Back: How Our Pro Bono Program Drives Positive Change
February 02, 2022
Tickers
MRK
3 Top Dow Jones Stocks to Safeguard Your Portfolio
January 27, 2022
From StockNews.com
Our Disability Inclusiveness Earns Top Employer Award
January 26, 2022
Tickers
MRK
Tickers
MRK
Catalyst Pharmaceuticals: A Biotech Stock Worth Owning
January 18, 2022
From StockNews.com
Merck and Ridgeback Announce Supply Agreement With UNICEF for Molnupiravir, an Investigational Oral Antiviral COVID-19 Medicine
January 18, 2022
Tickers
MRK
Is electroCore a Good Stock to Add to Your Healthcare Portfolio?
January 14, 2022
From StockNews.com
A Nobel Prize for a Longtime Merck Collaborator
January 14, 2022
Tickers
MRK
The 3 Best S&P 500 High Yield Dividend Stocks For 2022
January 12, 2022
From StockNews.com
2 Dividend Growth Stocks to Add to Your Income Portfolio in January
January 12, 2022
From StockNews.com
Does Teva Pharmaceutical Deserve a Place in Your 2022 Portfolio?
January 12, 2022
From StockNews.com
Better Buy for 2022: Merck vs. AstraZeneca
January 11, 2022
From StockNews.com
Is Now a Good Time to Scoop Up Shares of Canopy Growth?
January 11, 2022
From StockNews.com
Merck Announces Additional $150M Investment Through 2025 to Help End Maternal Mortality Inequities
January 10, 2022
Tickers
MRK
From StockNews.com
From Contrarian Outlook
How Merck Is Prioritizing Supply
January 07, 2022
Tickers
MRK
Showing Our Gratitude: Addressing COVID-19 Takes a Global Effort
January 05, 2022
Tickers
MRK
4 Drug Manufacturing Stocks to Add to Your Dividend Portfolio in January
December 28, 2021
From StockNews.com
Merck and Ridgeback's Molnupiravir Receives U.S. FDA Emergency Use Authorization for the Treatment of High-Risk Adults With Mild to Moderate COVID-19
December 28, 2021
Tickers
MRK
Tickers
MRK
Tickers
MRK
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.